Avalo Therapeutics, Inc. AVTX

15.47 (0.25) (1.59%) as of 25 Sep
Market cap
$843.1M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
98.37 134.57 7.42 13.19 54.64 18.96 11.26 10.67 2.47 5.14
Receivables
— 0.61 0.14 1.92 4.80 4.39 5.24 6.08 7.11 0.13
Inventory
— — — 0.02 0.04 0.00 0.02 0.32 0.38 —
Total current assets
105.29 138.89 8.40 16.42 61.85 26.01 17.72 21.93 10.67 5.66
Property, Plant, Equpment (Net)
0.46 1.21 1.97 2.41 2.70 1.61 1.45 0.59 0.04 0.04
Goodwill and Intangible Assets (Total)
10.50 10.50 10.50 14.41 14.45 15.99 16.84 18.17 31.96 —
Long-term assets (Other)
0.21 0.13 0.13 0.13 1.23 0.15 0.10 0.08 0.13 0.06
Total non-current assets
11.17 11.84 12.60 16.95 18.37 17.75 18.39 48.32 32.13 0.11
Total Assets
116.46 150.73 20.99 33.37 80.21 43.76 36.11 70.25 42.81 5.77
Notes Payable
— — — 5.93 — — — — — —
Accounts Payable
0.14 0.28 0.45 2.88 3.37 2.57 2.08 1.45 1.30 1.01
Accrued Expenses
12.80 6.32 4.17 13.21 16.52 11.31 5.64 14.33 7.53 0.95
Current Part of Debt
— — — 6.46 0.49 0.43 0.16 1.05 — 2.35
Current Part of Taxes to Pay
— — — — — — 0.55 2.03 2.26 —
Current Revenue (Deferred)
— — — 0.09 — — — — — —
Other current liabilities
— 0.36 — 12.77 16.03 12.23 9.38 0.86 7.85 0.95
Total current liabilities
12.94 6.96 4.62 22.11 19.89 15.23 12.16 26.22 11.09 4.31
Long Term Debt (Total)
— — — 13.49 32.83 3.04 1.11 14.33 — —
Long Term Tax Liability (Deferred)
0.43 0.27 0.16 0.14 0.11 0.09 0.09 0.07 0.01 —
Non-current Liabilities (Other)
20.04 10.47 8.92 8.54 4.30 3.88 1.11 2.03 3.85 1.25
Total non-current liabilities
20.47 10.74 9.07 22.17 37.24 3.97 2.95 23.13 3.86 1.25
Total liabilities
33.41 17.70 13.69 44.28 57.13 19.19 15.11 49.34 14.95 5.56
Additional Paid In Capital
531.49 503.29 342.44 292.91 285.24 202.28 135.24 119.08 83.34 70.23
Preferred Stock (Total)
— — — — — 0.00 0.00 0.00 — —
Common Stock (Net)
0.02 0.01 0.00 0.00 0.01 0.08 0.04 0.04 0.03 0.01
Retained Earnings
(448.52) (370.26) (335.13) (303.82) (262.17) (177.79) (114.29) (98.22) (58.17) (70.04)
Shareholders Equity (Other)
— — — — — — — — 2.66 —
Common Equity (Total)
83.05 133.03 7.30 (10.91) 23.08 24.56 20.99 20.90 27.86 0.21
Shareholders Equity (Total)
83.05 133.03 7.30 (10.91) 23.08 24.56 21.00 20.91 27.86 0.21
Shareholders Equity and Liabilities (Total)
116.46 150.73 20.99 33.37 80.21 43.76 36.11 70.25 42.81 5.77
Shares (Common)
18.51 10.47 0.80 0.04 0.04 0.03 0.02 0.01 0.01 0.00
Shares (Preferred)
0.02 0.02 — — — 0.00 0.00 0.00 — —
Shareholders Equity (Tangible)
72.55 122.53 (3.20) (25.32) 8.64 8.57 4.16 2.73 (4.10) 0.21
Net Debt
(98.37) (134.56) (7.42) 6.76 (21.32) (15.49) (9.99) 4.71 (2.47) (2.79)
Total Debt
— — — 19.95 33.32 3.46 1.27 15.38 — 2.35

Fold the line items

In millions of $ except per-share values · columns are period end dates